|
Pituitary Tumors constitute approximately fifteen (15 %)
percent of all Brain Tumors. The Pituitary Gland lies
underneath the Brain within a protective bone structure called
the "Sella Turcica" (so named because early anatomists believed
that it looked like a "Turkish Saddle".) The Pituitary Gland is
commonly referred to as the "Master Gland" of the body,
because of its central role in making and controlling hormones,
which themselves influence the functioning of the other hormone
producing glands which make up the "Endocrine" system
of our bodies. The Pituitary Gland has several anatomical parts,
including an Anterior (front) Lobe, a Posterior (rear)
Lobe, as well as, an Intermediate portion and a
"Stalk", which connects the Pituitary Gland to the
overlying Brain structure, called the "Hypothalamus".
As in other instances in life, when one believes that they are the
"Master" there is usually a "Higher Authority". In this case the
Hypothalamus is the "Higher Authority" to the Pituitary
Gland.
The Neurosurgical Consultants' staff have a long standing and
specific interest in Pituitary Tumors. We have prepared a rather
comprehensive review of the entire subject of Pituitary Tumors and
urge you to consider taking time to consult that reference which is
available in the
Downloads & Information section
this website.
In addition, there are many websites devoted to the Pituitary Gland
and Pituitary Tumors. Some of these are reliable, while some are
misleading. We can recommend, as an adjunct, the website of
The Pituitary Network Association
as a reliable primary resource.
The Symptoms that a patient will manifest depend on the
type of cell making up the tumor, the degree of local "invasion" of
the Skull Base (by aggressive tumor varieties) and the size of the
tumor.
Some small tumors can create serious clinical problems, because they
secrete excessive amounts of hormones, which then cause
deleterious effects. Examples of such diseases resulting from
the hyper-secretion of hormones that frequently occur in patients
harboring very small tumors are: Cushing's (resulting
from an overproduction of ACTH which causes the Adrenal
Glands to massively over produce steroids); Acromegaly or
Gigantism (resulting from an overproduction of Growth
Stimulating Hormone) and Hypersecretion of Prolactin
(Prolactin overproduction results in breast milk production even in
male patients as well as other hormone abnormalities).
|
| |
Another tumor that over produces the hormone PROLACTIN, can
cause women to stop their menstrual cycle, produce breast milk
and be unable to conceive a child. In men, this Prolactin
secreting tumor can cause their breasts to grow, and produce
milk, while also inducing testicular atrophy and impotence.
Once again the tumors can vary from quite small, to very large.
The majority of Pituitary Gland tumors arise from
cells that do not produce any hormones. This is known as
the "NULL CELL" tumors, which tend to become quite large
(see Figure 1) and grow beyond the confines of the bone
of the Sella Turcica. These large tumors often compress
the visual sensory apparatus (Optic Nerves and Optic Chiasm),
resulting in impaired vision or blindness. Patients are
often not aware of the subtle early changes of visual
impairment and only become aware of the change in vision when
they either cannot see out of one eye, or their peripheral vision has
deteriorated. As the tumor grows above the Sella Turcica, it
stretches the Optic Nerves, as well as the blood supply to the nerves
and the Optic Chiasm thus progressively impairing their
function. Tumors that "hypersecrete" can also grow to
prodigious size. An example of such a Prolactin hypersecreting
tumor is presented in Figures 3A & B.)
Pituitary Tumors are almost always benign although there
is a small percentage that can be malignant.
Nevertheless, even some benign tumors can be very aggressive,
resulting in local invasion. This can present quite a
management challenge such as when the tumor invades the
Cavernous Sinus (an anatomical structure lying beside the Sella
Turcica where the Carotid Arteries and Cranial Nerves 3/4/5 & 6 exist.
(See Figures 1 & 3)
The diagnosis of a Pituitary Tumor is usually made with MRI or
CT scanning. Endocrinological evaluation is an integral
part of the investigation of these patients.
There are options for treatment which include "masterful
inactivity and cat-like observation" (also known as
"do nothing"), hormonal therapy, surgery and
radiation therapy. "Observation" is appropriate for some small tumors,
including some Prolactin secreting tumors in young women, who do not
wish to become pregnant. Follow-up evaluations, including
Endocrinological management and MRI scanning, is
mandatory for patients who choose this option.
For hormonally active tumors, endocrinologists often prefer to
treat patients for extended periods of time with medications.
While this remains a contentious area between the disciplines of
Endocrinology and Neurosurgery, there is credible scientific
and clinical evidence to consider medical management in some
patients. There are times when a surgeon would prefer to see
the tumor reduced in size by medication prior to removing
it. In other instances, the patient may be a very poor
surgical candidate by virtue of intercurrent diseases. Many
patients, who initially try the medications, find the side effects
intolerable and strongly prefer surgical management.
The case illustrated in Figures 3A & B is one of a 33
year old male referred from a Neuro-ophthalmologist with
severe visual impairment. His Prolactin level was 10,761
(normal range is 3.0-30.0). Other aspects of his Pituitary
function were impaired as well including Steroid production
(Serum Cortisol >2/ Luteinizing Hormone 0.7/Testosterone
10/Somatomedin-C 45.4.) The Endocrinological consultant made
an excellent case for attempting "agonist" therapy
(medications that act against the production of Prolactin) as
a primary form of management. This treatment plan consists of
high dose "agonist" medication for 4 weeks after which follow
up blood Prolactin levels, MRI scan and a visual field
examination are carried out. In the event that there is
worsening of the visual field or no significant improvement,
surgical intervention becomes appropriate. Long-term
medication is required in those cases which do respond to this
medical regimen as this patient has.
|
| |
The choice of surgical approach in the management of
Pituitary Tumors primarily relates to their size, configuration,
tissue density, degree of local "invasion", the skill level and
experience of the Neurosurgeon. A standard surgical approach
utilizes Transsphenoidal Microneurosurgical techniques. While
most Pituitary tumors can be managed this way, there are some
technical limitations. A Craniotomy (opening of the skull) approach
is occasionally required particularly for giant tumors or those
with a dense surrounding capsule and/or dense fibrous tissue
component. Transsphenoidal Surgery is the mainstay
operation for these tumors. This approach is through a small
opening in the nose. For those Neurosurgeons with a large experience
(over 500 cases), this commonly allows for a complete surgical
removal of the tumor. In most instances, the Pituitary Gland and its
function can be entirely preserved.
Minimally Invasive Microendoscopic
Transsphenoidal Techniques are also available for some of
these tumors. These techniques are accomplished using a
modified Transsphenoidal avenue. These procedures are
available in some institutions as demonstrated in the accompanying
photos from our practice. This approach also has some limitations,
nevertheless it is highly recommended for many tumors.
There are rare circumstances when simultaneous Transsphenoidal
and Craniotomy approaches are require. Many of these involve the
specialists who make up the
Skull Base Tumor Team.
In the past, radiation therapy for Pituitary Tumors was
associated with some serious risk of damage to the visual
sensory apparatus as well as the Temporal Lobes. Modern
radiation therapy, particularly Stereotactic Radiosurgery, has
made these complications less likely.
Radiation Therapy of any variety is rarely appropriate as an
initial form of treatment, since one would not wish to
treat a tumor without having biopsy confirmation of the cell
type. In addition, it is inappropriate to radiate in
cases where the tumor is exerting significant pressure upon, and
displacing, the visual sensory apparatus. Radiation Therapy to a
large tumor, without prior decompression, runs the serious risk of
causing the tumor and the visual sensory apparatus to swell, with the
attendant consequence of blindness.
Radiation therapy can be very effective in controlling the
residual tumor in cases of non-secreting tumors, in cases of locally
aggressive, invasive tumors in cases of malignant tumors.
There are also indications to use Radiation Therapy in selected
cases of hormone secreting tumors, where Medical Therapy is
failing or poorly tolerated.
In all cases, long term follow up is important. This
includes yearly MRI scans for most of these patients
particularly for those where incomplete resection was carried
out.
Chemotherapy in the form of traditional and exotic
agents is generally unwarranted. Hormonal therapy is
commonly utilized for many patients, either alone, or in combination
with surgery.
The Neurosurgical Consultants' staff has a long standing and
specific interest in Pituitary Tumors. Dr. Lazar has operated on over
500 Pituitary Tumor patients and has long term follow-up on a large
majority of these cases.
We have prepared a rather comprehensive review of the entire
subject of Pituitary Tumors and urge you to consider taking time to
consult that reference which is available in the
Downloads & Information section
in this website.
In addition, there are many websites devoted to the Pituitary Gland
and Pituitary Tumors. Some of these are reliable, while some are
misleading. We can recommend, as an adjunct, the website of
The Pituitary Network Association
as a reliable primary resource.
Return to Top of Page
This page last edited on 2/19
|
|